Sarah Gill, MD
Gynecologic Oncology · Savannah, GANPI 1568782381
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,011 of the $9,312 with a category attached, or 86.0%. GSK accounts for 88.3% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $8,594, more than ten times the $126 reported in 2019.
Across 21 payments — averaging $443.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$8K
- Abbott$269
- Davol Inc.$163
- Caris MPI, Inc.$146
- Seagen Inc.$125
- Clovis Oncology, Inc.$100
- plus $288 from 7 others
Across 23 payments — averaging $17,108 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$376K
- Merck$17K
What the payments were for
- Travel & lodging$8,01186%
- Food & beverage$1,17513%
- Education$1261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 4 | $8,221 |
| Abbott | 2 | $269 |
| Davol Inc. | 1 | $163 |
| Caris MPI, Inc. | 3 | $146 |
| Seagen Inc. | 1 | $125 |
| Clovis Oncology, Inc. | 1 | $100 |
| Conmed Corporation | 1 | $93 |
| AbbVie | 2 | $64 |
| Intuitive Surgical | 1 | $49 |
| Tesaro, Inc. | 2 | $26 |
| Merck | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,312 in reported general payments places this provider in the 70th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 118 | $339 |
| Gabapentin | 19 | $148 |
| Ibuprofen | 37 | $101 |
| Prochlorperazine Maleate | 12 | $100 |
| Ondansetron Hcl | 11 | $81 |
| Tramadol Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Savannah
- James BurkeSavannah$276K
- Snehal BhoolaSavannah$9K
- William RichardsSavannah$320
- Benedict BenignoAtlanta$273K
- Sharad GhamandeAugusta$214K
- Ruchi GargNewnan$125K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Margarett EllisonMoultrie$81K
- Vijaya GalicGainesville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.